Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.7 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |